Emitents | Olainfarm, AS (213800WCG52W62ENOP27) |
Veids | Finanšu pārskati |
Valoda | EN |
Statuss | Publicēts |
Versija | |
Datums | 2013-11-29 19:12:10 |
Versijas komentārs | |
Teksts |
Olaine, November 29, 2013
In Nine
Months “Olainfarm” Increases Sales To 37.7 Million Lats
Consolidated profit
and loss statement of AS „Olainfarm” for nine months of 2013 shows
that the concern has made a net profit of 6.2 million lats (8.84
million euro). New nine months sales record has been set during
this period, as company has made sales of 37.7 million lats
(53.6 million euro). This is an increase by 7% compared to 2012.
“We
have experienced the most successful thirs quarter in our history,
as sales to Ukraine are back to normal. Ukraine historically
is one of the main markets of the company. In order to ensure
a longer term development and growth we have this year completed
nearly 30 registrations in 7 countries and started more
registration processes in Turkey, Mongolia and Mexico. In
cooperation with other producers we plan to strengthen and widen
our geographical presence, especially in CIS countries,” says
Valerijs Maligins, Chairman of the Management Board of AS
"Olainfarm". During 9 months of
2013 sales to all company’s main markets continued increasing
except for Ukraine and the UK. The most rapid sales increases
during the 9 months of 2013 were achieved to The Netherlands,
where sales grew by 2685%, Spain by 202%, Belarus by 62%, Latvia by
32% and Uzbekistan by 20%. Major sales markets of
AS “OlainFarm” during the 9 months of 2013 were Russia, Ukraine,
Latvia, Belarus and Kazakhstan. Annual meeting of
shareholders of AS “OlainFarm” held on April 29, 2013 approved
operating plan of the Concern. According to it, sales of the
Concern in 2013 are planned to be 59 million lats (84 million
euros), but the net profit will reach 11.5 million lats (16.4
million euros). According to this unaudited report for 9
months of 2013, during this period 64% of annual sales target and
54% of annual profit target is met.
A/s OlainFarm is one of the biggest pharmaceutical companies
in Latvia with 40 years of experience in production of medication
and chemical and pharmaceutical products. A basic principle of
company's operations is to produce reliable and effective top
quality products for Latvia and the rest of the world. Products
made by the Group are being exported to more than 30 countries of
the world, including the Baltics, Russia, other CIS, Europe, Asia,
North America and Australia. Information
prepared by:
|
Pielikumi |